Next-Generation Diagnostics - SciLifeLab symposium

Introduction

The SciLifeLab Clinical Diagnostics platform arranges an exciting one day symposium covering novel strategies for introduction of next-generation diagnostics in the diagnostic setup of e.g. cancer, cardiovascular diseases, and inherited conditions. We are glad to be able to announce a high-quality program with a distinguished faculty including prominent speakers from Germany, Finland, the Netherlands, Sweden, the UK, and the USA.

Useful links

Downloads

Conference Programme

Speakers

Olli Kallioniemi SciLifeLab, Stockholm , Sweden
Richard Rosenquist Uppsala University, Sweden
Clare Turnbull Queen Mary University of London, United Kingdom
Agneta Siegbahn Uppsala University, Sweden
Jan Nilsson Lund University , Sweden
Marcel Nelen Radboud University, Nijmegen , Netherlands
Valtteri Wirta SciLifeLab, Stockholm , Sweden
Anna Wedell Karolinska Institutet, Sweden
Heidi Howard Uppsala University, Sweden
Serena Nik-Zainal Wellcome Trust Sanger Institute, United Kingdom
Mark Ladanyi Memorial Sloan-Kettering Cancer Center, United States
Torsten Haferlach MLL Laboratory, Munich, Germany
Caroline Heckman FiMM, Helsinki , Finland
Ulf Gyllensten Uppsala University, Sweden
Ulf Landegren Uppsala University, Sweden

Venue

Karolinska Institutet

Aula Medica, Karolinska Institutet, Nobels väg 6, Stockholm, 171 65, Sweden

Useful links

Organised by

The Next-Generation Diagnostics (NGD) facility has been established at SciLifeLab Stockholm and Uppsala to facilitate the translation of new high-throughput (HTP) techniques, such as next-generation sequencing (NGS), microarray-based analyses and multiplex protein analysis, in biological samples into clinical use. The overall aim for the platform is to meet clinical diagnostic needs in the health-care and public health systems by providing service and support at the national level in order to promote and adapt the use of HTP techniques in routine diagnostics.

Contact information

91AV

Share: